Teva to commercialize Alexza Adasuve (loxapine) inhalation powder in US - Pharmaceutical Business Review
Teva to commercialize Alexza Adasuve (loxapine) inhalation powder in USPharmaceutical Business ReviewAdasuve (loxapine) inhalation powder is indicated for the acute treatment of agitation coupled with schizophrenia and bipolar I disorder.
Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What? - Seeking Alpha
Alexza Pharmaceuticals Has A Partner In Big Pharma, Now What?Seeking AlphaLoxapine, the active ingredient in Adasuve has previously been approved and used for years in agitation cases, but Alexza's delivery system allows the drug to be delivered in less than one second to the patient.
Teva - Alexza Sign Deal for Adasuve - Analyst Blog - NASDAQ.com - NASDAQ
Teva - Alexza Sign Deal for Adasuve - Analyst Blog - NASDAQ.